Assessing The Risk Of Infection In Patients Treated With Ocrelizumab As A result Of Low Levels Of IgM or IgG
Latest Information Update: 23 Jan 2020
At a glance
- Drugs Ocrelizumab (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
Most Recent Events
- 23 Jan 2020 New trial record